Vanda Pharmaceuticals Inc
10.88 - 11.25
9.24 - 21.44
Join Discuss about VNDA with like-minded investors
Next Dividend Date
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.
CEO: Mihael Polymeropoulos
HQ: 2200 Pennsylvania Ave NW Ste 300E Washington, 20037-1754 Washington Dc